Pulmonary vein-gap re-entrant atrial tachycardia following atrial fibrillation ablation: an electrophysiological insight with high-resolution mapping.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 Jul 2019
Historique:
received: 29 09 2018
accepted: 07 03 2019
pubmed: 21 3 2019
medline: 3 11 2020
entrez: 21 3 2019
Statut: ppublish

Résumé

The circuit of pulmonary vein-gap re-entrant atrial tachycardia (PV-gap RAT) after atrial fibrillation ablation is sometimes difficult to identify by conventional mapping. We analysed the detailed circuit and electrophysiological features of PV-gap RATs using a novel high-resolution mapping system. This multicentre study investigated 27 (7%) PV-gap RATs in 26 patients among 378 atrial tachycardias (ATs) mapped with Rhythmia™ system in 281 patients. The tachycardia cycle length (TCL) was 258 ± 52 ms with P-wave duration of 116 ± 28 ms. Three types of PV-gap RAT circuits were identified: (A) two gaps in one pulmonary vein (PV) (unilateral circuit) (n = 17); (B) two gaps in the ipsilateral superior and inferior PVs (unilateral circuit) (n = 6); and (C) two gaps in one PV with a large circuit around contralateral PVs (bilateral circuit) (n = 4). Rhythmia™ mapping demonstrated two distinctive entrance and exit gaps of 7.6 ± 2.5 and 7.9 ± 4.1 mm in width, respectively, the local signals of which showed slow conduction (0.14 ± 0.18 and 0.11 ± 0.10m/s) with fragmentation (duration 86 ± 27 and 78 ± 23 ms) and low-voltage (0.17 ± 0.13 and 0.17 ± 0.21 mV). Twenty-two ATs were terminated (mechanical bump in one) and five were changed by the first radiofrequency application at the entrance or exit gap. Moreover, the conduction time inside the PVs (entrance-to-exit) was 138 ± 60 ms (54 ± 22% of TCL); in all cases, this resulted in demonstrating P-wave with an isoelectric line in all leads. This is the first report to demonstrate the detailed mechanisms of PV-gap re-entry that showed evident entrance and exit gaps using a high-resolution mapping system. The circuits were variable and Rhythmia™-guided ablation targeting the PV-gap can be curative.

Identifiants

pubmed: 30891597
pii: 5396696
doi: 10.1093/europace/euz034
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1039-1047

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Seigo Yamashita (S)

Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, Japan.

Masateru Takigawa (M)

CHU Bordeaux, IHU Lyric, Université de Bordeaux, Bordeaux, France.

Arnaud Denis (A)

CHU Bordeaux, IHU Lyric, Université de Bordeaux, Bordeaux, France.

Nicolas Derval (N)

CHU Bordeaux, IHU Lyric, Université de Bordeaux, Bordeaux, France.

Yuichiro Sakamoto (Y)

Department of Cardiovascular Medicine, Toyohashi Heart Center, Toyohashi, Aichi, Japan.

Masaharu Masuda (M)

Kansai Rosai Hospital Cardiovascular Center, Hyogo, Japan.

Kohki Nakamura (K)

Division of Cardiology, Gunma Prefectural Cardiovascular Center, Gunma, Japan.

Yosuke Miwa (Y)

Department of Cardiology, Kyorin University Hospital, Tokyo, Japan.

Kenichi Tokutake (K)

Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, Japan.

Kenichi Yokoyama (K)

Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, Japan.

Michifumi Tokuda (M)

Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, Japan.

Seiichiro Matsuo (S)

Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, Japan.

Shigeto Naito (S)

Division of Cardiology, Gunma Prefectural Cardiovascular Center, Gunma, Japan.

Kyoko Soejima (K)

Department of Cardiology, Kyorin University Hospital, Tokyo, Japan.

Michihiro Yoshimura (M)

Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, Japan.

Michel Haïssaguerre (M)

CHU Bordeaux, IHU Lyric, Université de Bordeaux, Bordeaux, France.

Pierre Jaïs (P)

CHU Bordeaux, IHU Lyric, Université de Bordeaux, Bordeaux, France.

Teiichi Yamane (T)

Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH